4//SEC Filing
Tahir Misbah 4
Accession 0001415889-24-008169
CIK 0001496323other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 7:53 PM ET
Size
7.3 KB
Accession
0001415889-24-008169
Insider Transaction Report
Form 4
Tahir Misbah
CHIEF FINANCIAL OFFICER
Transactions
- Sale
Common Stock
2024-03-13$9.88/sh−2,897$28,608→ 92,961 total - Sale
Common Stock
2024-03-14$10.17/sh−2,543$25,864→ 90,418 total
Footnotes (3)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]This transaction was executed in multiple trades at prices ranging from $9.625 to $10.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]This transaction was executed in multiple trades at prices ranging from $9.80 to $10.43. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Documents
Issuer
IGM Biosciences, Inc.
CIK 0001496323
Entity typeother
Related Parties
1- filerCIK 0001787359
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 7:53 PM ET
- Size
- 7.3 KB